Work

OT3-01-13: Phase One Trial of Combined Temsirolimus, Erlotinib, and Cisplatin in Advanced Solid Tumors.

Year: 2011

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs11-ot3-01-13

Authors: M Maurer, K Kalinsky, K Crew, R Jayasena, J Forman, Y-K Lau, J Shaw, R Parsons, D Hershman

Institution: Columbia University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2092489306

FWCI:

Cites:

Cited by:

Related to: 10